Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-23-033960
Filing Date
2023-03-17
Accepted
2023-03-20 10:52:08
Documents
1
Period of Report
2023-03-17

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm239777d1_pre14a.htm PRE 14A 142073
  Complete submission text file 0001104659-23-033960.txt   143186
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

EIN.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40458 | Film No.: 23745205
SIC: 2834 Pharmaceutical Preparations